Fiche publication


Date publication

mai 2024

Journal

The Lancet. Oncology

Auteurs

Membres identifiés du Cancéropôle Est :
Pr MAYNADIE Marc


Tous les auteurs :
Sant M, Vener C, Lillini R, Rossi S, Bonfarnuzzo S, Marcos-Gragera R, Maynadié M, Innos K, Paapsi K, Visser O, Bernasconi A, Demuru E, Di Benedetto C, Mousavi SM, Blum M, Went P, Serraino D, Bennett D, Sánchez MJ, De Angelis R,

Résumé

Management of lymphoid malignancies requires substantial health system resources. Total national health expenditure might influence population-based lymphoid malignancy survival. We studied the long-term survival of patients with 12 lymphoid malignancy types and examined whether different levels of national health expenditure might explain differences in lymphoid malignancy prognosis between European countries and regions.

Référence

Lancet Oncol. 2024 05 1;: